CD8A and cancer: By combining the results from these algorithms, we found that in most cancers, ESRRA strongly contributed to the infiltration of natural killer cells and neutrophils, and weakened the infiltration of CD8+ T cells (Figures 2A, B; Supplementary Figure S8A).